Skip to search formSkip to main contentSkip to account menu

OspA protein

Known as: OspA vaccine, outer surface protein A 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2001
Highly Cited
2001
The genome of Borrelia burgdorferi encodes a large number of lipoproteins, many of which are expressed only at certain stages of… 
Highly Cited
2000
Highly Cited
2000
ABSTRACT The Lyme disease-associated spirochete, Borrelia burgdorferi, is maintained in enzootic cycles involvingIxodes ticks and… 
Highly Cited
1998
Highly Cited
1998
Treatment-resistant Lyme arthritis is associated with immune reactivity to outer surface protein A (OspA) of Borrelia burgdorferi… 
Highly Cited
1993
Highly Cited
1993
A total of 136 Borrelia burgdorferi sensu latu strains from various biological sources (ticks, human skin, and cerebrospinal… 
Highly Cited
1993
Highly Cited
1993
The current vaccine against tuberculosis, Mycobacterium bovis strain bacille Calmette-Guerin (BCG), offers potential advantages… 
Highly Cited
1992
Highly Cited
1992
Vaccination with recombinant outer surface protein A (OspA) has been shown to protect mice from infection with Borrelia… 
Highly Cited
1991
Highly Cited
1991
Borrelia burgdorferi dissemination to selected target organs was examined on days 1, 2, 3, 4, 7, 10, 15, 21, and 30 after… 
Highly Cited
1990
Highly Cited
1990
Lyme borreliosis is a tick-borne illness caused by Borrelia burgdorferi. The gene for outer surface protein A (OspA) from B… 
Highly Cited
1990
Highly Cited
1990
We have recently shown that viable Borrelia burgdorferi organisms induce a chronic infection associated with arthritis and…